Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Pharmaceutical isolators are special equipment used in the pharmaceutical industry to prevent contamination during manufacturing and other processes. They are designed to protect workers from exposure to drugs, prevent cross-contamination, and maintain the quality of the drugs. The global pharmaceutical isolator market is expected to grow due to factors such as the increasing pharmaceutical industry, research and development investments, and government regulations for drug safety. However, the high cost of installing and maintaining isolators may hinder market growth.
The global pharmaceutical isolator market is projected to reach USD 32,944.3 million by 2023, with a Compound Annual Growth Rate (CAGR) of 7.86% during the forecast period from 2018 to 2023. In 2017, the Americas led the market with a 36.4% share, followed by Europe and Asia-Pacific with shares of 34.0% and 24.7%, respectively.
The market is segmented based on the type of isolators, pressure, application, and end-user. Open isolators accounted for the largest market share of 60.5% in 2017, with a value of USD 12,622.5 million. Positive pressure isolators accounted for the largest market share of 55.5% in terms of pressure, valued at USD 11,581.1 million. Aseptic filling was the largest application segment with a market share of 27.9% and a value of USD 5,830.3 million. Pharmaceutical and biotechnological companies were the largest end-user segment, accounting for 45.8% of the market share and a value of USD 9,552.5 million.
In summary, pharmaceutical isolators are crucial equipment in the pharmaceutical industry to prevent contamination and ensure drug safety. The market is expected to grow due to the expanding pharmaceutical sector, increased research and development activities, and government regulations. However, the high cost of isolators may pose a challenge to market growth. The market is segmented based on isolator type, pressure, application, and end-user, with open isolators, positive pressure isolators, aseptic filling, and pharmaceutical and biotechnological companies being the dominant segments, respectively. The global pharmaceutical isolator market offers significant opportunities for manufacturers and suppliers in the industry.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | 8.30 |
Open System Isolator Market Highlights:
Open System Isolator Market Scenario
Open System Isolator Market Size was valued at USD 8.40 Billion in 2023. The Open System Isolator industry is projected to grow from USD 9.21 Billion in 2024 to USD 17.69 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period (2024 - 2032).
Pharmaceutical isolators are used to eliminate the risk of contamination and essential in many manufacturing and research activities. Open system isolators are commonly used in the pharmaceutical and biotechnology industry to maintain the aseptic environment and to protect the operator from hazardous elements. The growing pharmaceutical industry and increasing number of drug manufacturers, increasing research and development activities and stringent policies implemented by government and regulatory authorities to maintain the safety and efficacy of the drug are contributing to the growth of the market. According to the International Federation of Pharmaceutical Manufacturers & Associations global pharmaceutical industry will achieve the target of USD 1,430 billion by 2020.
The high costs of Open System Isolators, availability of other substitutes and scarcity of technicians may hamper the growth of the market during the assessment period.
Segmentation
The global open system isolator market has been segmented on the basis of pressure, application, and end-user.
On the basis of pressure, the market has been divided into positive pressure isolators and negative pressure isolators.
The market, by application, has been divided into fluid dispensing isolators, aseptic filling isolators, product contaminants isolators, sampling/weighing/distribution isolators, and others
The market, by end-user, has been segmented into pharmaceutical and biotechnological industries, academic & research institutes, hospitals and diagnostic laboratories, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The open system isolator market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European open system isolator market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The open system isolator in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The open system isolator market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Open System Isolator Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to hold the first place in the global open system isolator market due to the presence of well-established pharmaceutical industry, technological advancement in the region and adoption of high technology, and presence of strict government policies in the region. According to the International Trade Administration (ITA), in 2015, the biopharmaceutical industry in the US spent more than USD 75 billion on research and development activities, which is half of the global biopharma R&D spending.
The European market is expected to be the second-largest open system isolator global market. The market growth in this region is the result of an increasing number of research and development activities in the region, growing concern about the safety of the drug and increasing inspections by regulatory authorities. The contribution of Germany and France is noticeable in the growth of European open system isolator market. For instance, according to the report published by Germany Trade & Invest in 2017, the German pharmaceutical market was worth USD 45 billion (2017) and is the largest market in Europe and holds fourth place in the global pharmaceutical industry.
Asia-Pacific is expected to be the fastest-growing open system isolator global market during the forecast period owing to the presence of a strong generics market and increasing export of generic drugs from the countries like China and India. For instance, according to the Indian Brand Equity Foundation (Ministry of Commerce & Industry, Government of India), Indian companies exported pharmaceuticals worth USD 17.27 billion during 2017 to 2018 which is expected to grow at a rate of 30% to reach USD 20 billion by 2020.
The market in the Middle East & Africa is expected to account for the smallest share of the open system isolator global market due to poor infrastructure and slow development of the healthcare sector.
Key Players
Some of the key players in the open system isolator are Gelman Singapore Pte Ltd, COMECER S.p.A. cf. p.iva, IsoTech Design, LAF Technologies Pty Ltd, Fedegari Autoclavi S.p.A, Hosokawa Micron Ltd, Robert Bosch GmbH, MBRAUN, Schematic Engineering Industries, NuAire Inc, VanRx Pharmasystems Inc, Azbil Telstar, Getinge AB, Skan AG, Chamunda Pharma Machinery Pvt. Ltd., and GERMFREE
Global Open System Isolator Market, by Pressure
- Positive Pressure Isolators
- Negative Pressure Isolators
Global Open System Isolator Market, by Application
- Fluid Dispensing
- Product Contaminants
- Sampling/Weighing/Distribution
- Others
Global Open System Isolator Market, by End-User
- Pharmaceutical and Biotechnological Industries
- Academic & Research Institutes
- Hospitals and diagnostics laboratories
- Others
Global Open System Isolator Market, by Region
Americas
- North America
- US
- Canada
- South America
Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
- Middle East
- Africa
Intended Audience
- Open System Isolator Manufacturers
- Open System Isolator Distributors and Suppliers
- Healthcare Providers and Diagnostic Laboratories
- Pharmaceutical and Biotechnology companies
- Research Institutes and Academic Centers
- Contract research organizations (CROs)
- Market Research and Consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
